DBPi at ESMO Congress’22 representing multinational Prostate Cancer patient survey

Dr. Nils Drews and Dr. Henning Sievert at ESMO Congress 2022

We have recently conducted a QoL patient survey project which is also one of the largest digital survey ever conducted in patients with Prostate cancer.

The goal of this patient insights survey was to map patient experiences through the entire diagnostic and therapeutic patient journey, uncover expectations, and attitudes, and to identify challenges and unmet needs in diagnosis, therapy patterns, care teams, quality of life (QoL), patient organizations, and resources.

We are delighted to announce that the abstract of this survey has been selected for poster presentation at the ESMO Congress 2022. Our team including Dr. Nils Drews and Dr. Henning Sievert along with Prof. Joe O’Sullivan, leading medical expert from Queen’s Hospital Belfast will be attending this years’ ESMO Congress from 9-13 September in Paris, and will be there to answer any queries you may have regarding this survey. We are looking forward to meeting with you and discussing your needs.

About ESMO Congress

The ESMO Congress is the most influential oncology platform for clinicians, researchers, patient advocates, and healthcare industry representatives from all over the world. The 5-day event provides latest advances in the field of Oncology, an excellent educational programme and opportunity to interact with key opinion leaders from the industry.

This year the Congress offers participants the option to attend in person, in Paris, or online, through a virtual platform. You can learn more about the ESMO Congress at www.esmo.org.

To discuss your patient insights needs, contact us here.